FMC (FMC) Reports Q2 Earnings: What Key Metrics Have to Say

01.08.25 04:00 Uhr

Werte in diesem Artikel
Aktien

31,77 EUR -0,74 EUR -2,28%

42,23 EUR 0,27 EUR 0,64%

69,00 EUR 0,00 EUR 0,00%

Indizes

PKT PKT

1.977,0 PKT -33,8 PKT -1,68%

2.054,2 PKT -36,9 PKT -1,77%

23.329,2 PKT -419,6 PKT -1,77%

8.740,1 PKT -157,2 PKT -1,77%

1.882,9 PKT -18,7 PKT -0,98%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

196,5 PKT -2,4 PKT -1,20%

570,8 PKT -7,2 PKT -1,25%

12.310,1 PKT -213,7 PKT -1,71%

23.407,0 PKT -322,0 PKT -1,36%

23.439,9 PKT -287,9 PKT -1,21%

9.020,1 PKT -154,2 PKT -1,68%

16.380,2 PKT -258,1 PKT -1,55%

1.854,4 PKT -8,4 PKT -0,45%

FMC (FMC) reported $1.05 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 1.2%. EPS of $0.69 for the same period compares to $0.63 a year ago.The reported revenue represents a surprise of +8.82% over the Zacks Consensus Estimate of $965.4 million. With the consensus EPS estimate being $0.59, the EPS surprise was +16.95%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how FMC performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Geographic Revenue- Latin America: $310 million versus $296.12 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.9% change.Geographic Revenue- Europe, Middle East and Africa (EMEA): $260 million compared to the $223.58 million average estimate based on two analysts. The reported number represents a change of +29.2% year over year.Geographic Revenue- Asia: $159 million versus the two-analyst average estimate of $163.72 million. The reported number represents a year-over-year change of -16.8%.Geographic Revenue- North America: $321 million versus $294.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5.3% change.Revenue by Product- Insecticides: $525.3 million versus $487.74 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -7.7% change.Revenue by Product- Fungicides: $80.4 million compared to the $67.79 million average estimate based on two analysts. The reported number represents a change of +7.9% year over year.Revenue by Product- Herbicides: $376 million versus the two-analyst average estimate of $323.09 million. The reported number represents a year-over-year change of +11.7%.View all Key Company Metrics for FMC here>>>Shares of FMC have returned -7% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FMC Corporation (FMC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf FMC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Wer­bung

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
15.09.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
10.09.2025Fresenius Medical Care (FMC) St SellUBS AG
02.09.2025Fresenius Medical Care (FMC) St SellUBS AG
15.08.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
06.08.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
15.08.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
06.08.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
14.07.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
23.06.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.06.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
15.09.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
10.09.2025Fresenius Medical Care (FMC) St SellUBS AG
02.09.2025Fresenius Medical Care (FMC) St SellUBS AG
06.08.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
05.08.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen